• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伴有黑色素瘤优先表达抗原(PRAME)免疫阳性的CIC::DUX4肉瘤

CIC::DUX4 Sarcoma With Preferentially Expressed Antigen in Melanoma (PRAME) Immunopositivity.

作者信息

Grove John, Naous Rana

机构信息

Pathology and Laboratory Medicine, University of Pittsburgh Medical Center, Pittsburgh, USA.

Pathology, University of Pittsburgh Medical Center, Pittsburgh, USA.

出版信息

Cureus. 2025 May 31;17(5):e85154. doi: 10.7759/cureus.85154. eCollection 2025 May.

DOI:10.7759/cureus.85154
PMID:40599504
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12208817/
Abstract

-rearranged sarcomas are rare, high-grade, undifferentiated, small round cell sarcomas of bone and soft tissue classified by gene fusions involving the gene with other gene partners, most commonly the gene. These tumors tend to affect a wide age range, with a predilection for adult males, with the most common anatomical location being the deep soft tissues of the limbs or trunk. -rearranged sarcomas have proven not only to be challenging to diagnose but also to treat due to their high resistance to conventional therapies. Preferentially expressed antigen in melanoma (PRAME) is an immunohistochemical stain that was developed primarily for the diagnosis of melanoma and has been shown to also be expressed in other epithelial and mesenchymal tumors. To date, PRAME immunopositivity has not been reported in -rearranged sarcomas. Here, we report a 51-year-old male with a large gluteal undifferentiated small round cell sarcoma and bilateral lung metastases, whereby RNA sequencing confirmed the tumor as sarcoma. Interestingly, the sarcoma demonstrated very strong PRAME immunohistochemical positivity, a diagnostic finding that has not yet been reported on sarcomas and has potential use as a beneficial tool in the workup of a diagnostically challenging disease.

摘要

-重排肉瘤是罕见的、高级别、未分化的骨和软组织小圆细胞肉瘤,通过涉及该基因与其他基因伙伴(最常见的是基因)的基因融合进行分类。这些肿瘤倾向于影响广泛的年龄范围,以成年男性为主,最常见的解剖位置是四肢或躯干的深部软组织。-重排肉瘤已被证明不仅诊断具有挑战性,而且由于其对传统疗法的高度抗性,治疗也很困难。黑色素瘤优先表达抗原(PRAME)是一种免疫组织化学染色,主要用于黑色素瘤的诊断,并且已显示在其他上皮和间叶肿瘤中也有表达。迄今为止,尚未报道PRAME免疫阳性在-重排肉瘤中的情况。在此,我们报告一名51岁男性,患有巨大的臀部分化不良小圆细胞肉瘤并伴有双侧肺转移,通过RNA测序证实该肿瘤为肉瘤。有趣的是,该肉瘤显示出非常强的PRAME免疫组织化学阳性,这一诊断发现尚未在肉瘤中报道,并且在诊断具有挑战性的疾病的检查中具有作为有益工具的潜在用途。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5537/12208817/d4b28dad625a/cureus-0017-00000085154-i06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5537/12208817/f44969c76073/cureus-0017-00000085154-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5537/12208817/04f662b4cf5a/cureus-0017-00000085154-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5537/12208817/8923a46a31d1/cureus-0017-00000085154-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5537/12208817/e9a79fbcedca/cureus-0017-00000085154-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5537/12208817/b6bb3c2c27b2/cureus-0017-00000085154-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5537/12208817/d4b28dad625a/cureus-0017-00000085154-i06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5537/12208817/f44969c76073/cureus-0017-00000085154-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5537/12208817/04f662b4cf5a/cureus-0017-00000085154-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5537/12208817/8923a46a31d1/cureus-0017-00000085154-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5537/12208817/e9a79fbcedca/cureus-0017-00000085154-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5537/12208817/b6bb3c2c27b2/cureus-0017-00000085154-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5537/12208817/d4b28dad625a/cureus-0017-00000085154-i06.jpg

相似文献

1
CIC::DUX4 Sarcoma With Preferentially Expressed Antigen in Melanoma (PRAME) Immunopositivity.伴有黑色素瘤优先表达抗原(PRAME)免疫阳性的CIC::DUX4肉瘤
Cureus. 2025 May 31;17(5):e85154. doi: 10.7759/cureus.85154. eCollection 2025 May.
2
CIC/ATXN1-rearranged tumors in the central nervous system are mainly represented by sarcomas: A comprehensive clinicopathological and epigenetic series.中枢神经系统中CIC/ATXN1重排的肿瘤主要为肉瘤:一项全面的临床病理和表观遗传学研究系列。
Brain Pathol. 2025 Mar;35(2):e13303. doi: 10.1111/bpa.13303. Epub 2024 Oct 23.
3
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
4
Machine Learning-Supported Diagnosis of Small Blue Round Cell Sarcomas Using Targeted RNA Sequencing.基于靶向 RNA 测序的机器学习辅助诊断小蓝圆细胞肉瘤。
J Mol Diagn. 2024 May;26(5):387-398. doi: 10.1016/j.jmoldx.2024.02.002. Epub 2024 Feb 21.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
6
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
7
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
8
Does Augmenting Irradiated Autografts With Free Vascularized Fibula Graft in Patients With Bone Loss From a Malignant Tumor Achieve Union, Function, and Complication Rate Comparably to Patients Without Bone Loss and Augmentation When Reconstructing Intercalary Resections in the Lower Extremity?对于因恶性肿瘤导致骨缺损的患者,在重建下肢节段性切除时,采用带血管游离腓骨移植来增强照射后的自体骨移植,其骨愈合、功能及并发症发生率与无骨缺损且未进行增强的患者相比是否相当?
Clin Orthop Relat Res. 2025 Jun 26. doi: 10.1097/CORR.0000000000003599.
9
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
10
Nivolumab for adults with Hodgkin's lymphoma (a rapid review using the software RobotReviewer).纳武单抗用于成人霍奇金淋巴瘤(使用RobotReviewer软件进行的快速综述)
Cochrane Database Syst Rev. 2018 Jul 12;7(7):CD012556. doi: 10.1002/14651858.CD012556.pub2.

本文引用的文献

1
CIC-Rearranged Sarcomas: An Intriguing Entity That May Lead the Way to the Comprehension of More Common Cancers.CIC重排肉瘤:一种可能为理解更常见癌症指明方向的有趣实体。
Cancers (Basel). 2022 Nov 2;14(21):5411. doi: 10.3390/cancers14215411.
2
PRAME Expression in Cancer. A Systematic Immunohistochemical Study of >5800 Epithelial and Nonepithelial Tumors.PRAME 在癌症中的表达。对>5800 例上皮性和非上皮性肿瘤的系统免疫组织化学研究。
Am J Surg Pathol. 2022 Nov 1;46(11):1467-1476. doi: 10.1097/PAS.0000000000001944. Epub 2022 Aug 16.
3
Systemic treatments and outcomes in CIC-rearranged Sarcoma: A national multi-centre clinicopathological series and literature review.
CIC 重排肉瘤的系统治疗和结果:全国多中心临床病理系列和文献复习。
Cancer Med. 2022 Apr;11(8):1805-1816. doi: 10.1002/cam4.4580. Epub 2022 Feb 17.
4
Sarcomas With CIC-rearrangements Are a Distinct Pathologic Entity With Aggressive Outcome: A Clinicopathologic and Molecular Study of 115 Cases.伴有CIC重排的肉瘤是一种具有侵袭性预后的独特病理实体:115例病例的临床病理和分子研究
Am J Surg Pathol. 2017 Jul;41(7):941-949. doi: 10.1097/PAS.0000000000000846.
5
CIC-DUX4 fusion-positive round-cell sarcomas of soft tissue and bone: a single-institution morphological and molecular analysis of seven cases.软组织和骨的CIC-DUX4融合阳性圆形细胞肉瘤:单机构7例病例的形态学和分子分析
Histopathology. 2016 Oct;69(4):624-34. doi: 10.1111/his.12985. Epub 2016 Jun 23.
6
Round cell sarcoma with CIC-DUX4 gene fusion: Discussion of the distinctive cytomorphologic, immunohistochemical, and molecular features in the differential diagnosis of round cell tumors.伴有CIC-DUX4基因融合的圆形细胞肉瘤:圆形细胞肿瘤鉴别诊断中独特细胞形态学、免疫组化及分子特征的探讨
Cancer Cytopathol. 2016 May;124(5):350-61. doi: 10.1002/cncy.21685. Epub 2016 Jan 22.
7
CIC-rearranged Sarcomas: A Study of 20 Cases and Comparisons With Ewing Sarcomas.CIC重排肉瘤:20例研究及与尤因肉瘤的比较
Am J Surg Pathol. 2016 Mar;40(3):313-23. doi: 10.1097/PAS.0000000000000570.
8
High prevalence of CIC fusion with double-homeobox (DUX4) transcription factors in EWSR1-negative undifferentiated small blue round cell sarcomas.EWSR1 阴性未分化小圆蓝细胞肉瘤中高频出现 CIC 融合与双同源盒(DUX4)转录因子。
Genes Chromosomes Cancer. 2012 Mar;51(3):207-18. doi: 10.1002/gcc.20945. Epub 2011 Nov 10.
9
Fusion between CIC and DUX4 up-regulates PEA3 family genes in Ewing-like sarcomas with t(4;19)(q35;q13) translocation.在伴有t(4;19)(q35;q13)易位的尤因样肉瘤中,CIC与DUX4的融合上调了PEA3家族基因。
Hum Mol Genet. 2006 Jul 1;15(13):2125-37. doi: 10.1093/hmg/ddl136. Epub 2006 May 22.